SANUWAVE Health, Inc. Net Income (Loss) Available to Common Stockholders, Diluted
SANUWAVE Health, Inc. (SNWV) reported Net Income (Loss) Available to Common Stockholders, Diluted of -$682.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2026-08-06
- SANUWAVE Health, Inc. net income (loss) available to common stockholders, diluted for the quarter ending 2026-06-30 was -$682.00K.
- SANUWAVE Health, Inc. net income (loss) available to common stockholders, diluted for the quarter ending 2025-12-31 was $188.00K.
- SANUWAVE Health, Inc. net income (loss) available to common stockholders, diluted for the quarter ending 2025-09-30 was $4.23M.
- SANUWAVE Health, Inc. net income (loss) available to common stockholders, diluted for the quarter ending 2025-06-30 was -$439.00K, a 106.69% decline year-over-year.
- SANUWAVE Health, Inc. net income (loss) available to common stockholders, diluted for fiscal 2025 was $3.71M.
- SANUWAVE Health, Inc. net income (loss) available to common stockholders, diluted for fiscal 2024 was -$33.08M.
| Period end | Net Income (Loss) Available to Common Stockholders, Diluted 3 month | Net Income (Loss) Available to Common Stockholders, Diluted 3 month as first filed | Net Income (Loss) Available to Common Stockholders, Diluted 6 month | Net Income (Loss) Available to Common Stockholders, Diluted 6 month as first filed | Net Income (Loss) Available to Common Stockholders, Diluted 9 month | Net Income (Loss) Available to Common Stockholders, Diluted 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$682.00K 10-Q · filed 2026-08-06 | -$2.12M 10-Q · filed 2026-08-06 | ||||
| 2025-12-31 | $188.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $4.42M derived: sum of 2 quarters · filed 2026-03-26 | $3.98M derived: sum of 3 quarters · filed 2026-08-06 | $3.71M 10-K · filed 2026-03-26 | ||
| 2025-09-30 | $4.23M 10-Q · filed 2025-11-06 | $3.79M derived: sum of 2 quarters · filed 2026-08-06 | $3.52M 10-Q · filed 2025-11-06 | |||
| 2025-06-30 | -$439.00K 10-Q · filed 2026-08-06 | $65.00K 10-Q · filed 2025-08-07 | -$5.57M 10-Q · filed 2026-08-06 | -$4.62M 10-Q · filed 2025-08-07 | ||
| 2024-12-31 | -$14.46M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -$35.12M derived: sum of 2 quarters · filed 2026-03-26 | -$28.55M derived: sum of 3 quarters · filed 2026-03-26 | -$33.08M 10-K · filed 2026-03-26 | ||
| 2024-09-30 | -$20.66M 10-Q · filed 2025-11-06 | -$14.10M derived: sum of 2 quarters · filed 2025-11-06 | -$18.62M 10-Q · filed 2025-11-06 | |||
| 2024-06-30 | $6.56M 10-Q · filed 2025-08-07 | $2.03M 10-Q · filed 2025-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |